Relationship between gene mutations and protein expressions of PDGFR α and C-kit in gastrointestinal stromal tumors.

about

Relationship between gene mutations and protein expressions of PDGFR α and C-kit in gastrointestinal stromal tumors.

Item

http://www.wikidata.org/entity/Q41846953

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relationship between gene muta ...... strointestinal stromal tumors.

@en

type

Item

label

Relationship between gene muta ...... strointestinal stromal tumors.

@en

prefLabel

Relationship between gene muta ...... strointestinal stromal tumors.

@en

P1476

Relationship between gene muta ...... astrointestinal stromal tumors

@en

P2093

H X Tong

http://www.w3.org/2001/XMLSchema#string

J Y Wang

http://www.w3.org/2001/XMLSchema#string

J Zhu

http://www.w3.org/2001/XMLSchema#string

Jun-Yi He

http://www.w3.org/2001/XMLSchema#string

Wei-Qi Lu

http://www.w3.org/2001/XMLSchema#string

Y B Shao

http://www.w3.org/2001/XMLSchema#string

Y Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes.

PDGFRA activating mutations in gastrointestinal stromal tumors.

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

P304

7592-7598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26221304

http://www.w3.org/2001/XMLSchema#string

P932

4509249

http://www.w3.org/2001/XMLSchema#string